Professor: If LymPro does what we all think it wil
Post# of 30028
Posted On: 10/22/2014 11:27:49 PM
Re: biotechexpert #9523
Professor: If LymPro does what we all think it will do in 2015, AMBS won't run out of money. That's why everyone is on pins and needles about all of Lympro's delays. If management can deliver LymPro and successfully launch it in December with strong data, a marketing blitz, and several clinical trial work orders....we'll all be fine.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼